Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
M.D. Anderson Cancer Center
Washington University School of Medicine
Washington University School of Medicine
Yale University
Baptist Health South Florida
Maastricht University Medical Center
GCS Ramsay Santé pour l'Enseignement et la Recherche
Tianjin Medical University Cancer Institute and Hospital
Vanderbilt-Ingram Cancer Center
The Cooper Health System
Exelixis
Duke University
King's College Hospital NHS Trust
University of California, San Francisco